Prescription drug · ANDA
Lacosamide NDC 85742-009
Lacosamide 100 mg/1 · Tablet, Film coated · Oral · Kanchan Healthcare Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85742-009-07 | 85742000907 | 6 BLISTER PACK in 1 CARTON (85742-009-07) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Aug 6, 2025 | |
| 85742-009-08 | 85742000908 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (85742-009-08)Marketed from Aug 6, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lacosamide
- Generic name (nonproprietary)
- lacosamide
- Active ingredients
- Lacosamide — 100 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Kanchan Healthcare Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218014
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 85742-009_9e55b694-312b-480c-a20f-a6ed325906d7SPL ID 9e55b694-312b-480c-a20f-a6ed325906d7SPL set ID 5c03b90e-6985-4005-b6c5-44626d0600d7RxCUI 809987, 809992, 809996, 810000UNII 563KS2PQY5UPC 0385742009086, 0385742008089, 0385742010082, 0385742008072, 0385742011089
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N485742000907followed by a unit qualifier and the quantityPackage 85742-0009-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Lacosamide tablets are indicated for: Treatment of partial-onset seizures in patients 1 month of age and older (1.1) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older (1.2) 1.1 Partial-Onset Seizures Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide tablet is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 218014
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals, Inc | 10135-799 |
| Lacosamide | Lacosamide 100 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals, Inc | 10135-800 |
| Lacosamide | Lacosamide 150 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals, Inc | 10135-801 |
| Lacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals, Inc | 10135-802 |
| Lacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | Kanchan Healthcare Inc | 85742-008 |
| Lacosamide | Lacosamide 150 mg/1 | Tablet, Film coatedOral | Kanchan Healthcare Inc | 85742-010 |
| Lacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | Kanchan Healthcare Inc | 85742-011 |